Cargando…
Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
BACKGROUND: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) require lifelong treatment. The aim of the present study was to investigate adherence to disease-specific treatment in patients with PAH or CTEPH. METHODS: The study comprised an adult populat...
Autores principales: | Kjellström, Barbro, Sandqvist, Anna, Hjalmarsson, Clara, Nisell, Magnus, Näsman, Per, Ivarsson, Bodil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720683/ https://www.ncbi.nlm.nih.gov/pubmed/33313301 http://dx.doi.org/10.1183/23120541.00299-2020 |
Ejemplares similares
-
Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008–2016
por: Kjellström, Barbro, et al.
Publicado: (2019) -
Health-related quality of life, treatment adherence and psychosocial support
in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary
hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2018) -
Prevalence of potential drug–drug interactions with disease‐specific treatments in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A registry study
por: Norell, Puck N., et al.
Publicado: (2022) -
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
por: Kjellström, Barbro, et al.
Publicado: (2022) -
Outpatient specialist clinics for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the Nordic countries
por: Kjellström, Barbro, et al.
Publicado: (2020)